Severe ischemic bowel necrosis caused by terlipressin during treatment of hepatorenal syndrome
Clinical and Molecular Hepatology
;
: 417-420, 2013.
Artículo
en Inglés
| WPRIM
| ID: wpr-34823
ABSTRACT
Terlipressin is a vasopressin analogue that is widely used in the treatment of hepatorenal syndrome or variceal bleeding. Because it acts mainly on splanchnic vessels, terlipressin has a lower incidence of severe ischemic complications than does vasopressin. However, it can still lead to serious complications such as myocardial infarction, skin necrosis, or bowel ischemia. Herein we report a case of severe ischemic bowel necrosis in a 46-year-old cirrhotic patient treated with terlipressin. Although the patient received bowel resection, death occurred due to ongoing hypotension and metabolic acidosis. Attention should be paid to patients complaining of abdominal pain during treatment with terlipressin.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Asunto principal:
Vasoconstrictores
/
Bilirrubina
/
Síndrome Hepatorrenal
/
Lipresina
/
Tomografía Computarizada por Rayos X
/
Resultado Fatal
/
Creatinina
/
Electrocardiografía
/
Mucosa Intestinal
/
Intestinos
Límite:
Humanos
/
Masculino
Idioma:
Inglés
Revista:
Clinical and Molecular Hepatology
Año:
2013
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS